Publication Name	World Journal of Clinical Cases
Manuscript ID	87917
Country	China

Received	2023-09-25 07:27
Peer-Review Started	2023-09-25 07:27
To Make the First Decision
Return for Revision	2023-10-17 07:32
Revised	2023-10-18 08:23
Second Decision	2023-10-30 00:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-11-02 08:29
Articles in Press	2023-11-02 08:29
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-10-27 07:20
Typeset the Manuscript	2023-11-10 07:50
Publish the Manuscript Online	2023-11-16 04:01

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Randomized Clinical Trial
Article Title	Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke
Manuscript Source	Unsolicited Manuscript
All Author List	Jian-Quan Zhang and Zhi-Bin Pan
ORCID	Author(s) ORCID Number Jian-Quan Zhang http://orcid.org/0009-0004-2225-5810
Funding Agency and Grant Number
Corresponding Author	Jian-Quan Zhang, MSc, Associate Chief Physician, Department of Emergency Medicine, The First Affiliated Hospital of Jiangxi Medical College, No. 31 Qingfeng Road, Shangrao 334000, Jiangxi Province, China. tuju0931042072@126.com
Key Words	Aspirin; Acute stroke; Antiplatelet therapy; Recurrent stroke; Recurrent vascular events; Myocardial infarction
Core Tip	While aspirin use within 48 h of acute stroke showed improved functional outcomes, it did not significantly reduce the risk of recurrent vascular events compared to no aspirin. The safety profile of aspirin was acceptable and comparable to no aspirin. Further research with larger sample sizes and longer follow-up is required to validate these findings and determine the optimal timing and dose of aspirin initiation after an acute stroke.
Publish Date	2023-11-16 04:01
Citation	Zhang JQ, Pan ZB. Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke. World J Clin Cases 2023; 11(32): 7814-7821
URL	https://www.wjgnet.com/2307-8960/full/v11/i32/7814.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i32.7814

Full Article (PDF)	WJCC-11-7814-with-cover.pdf
Full Article (Word)	WJCC-11-7814.docx
CONSORT 2010 Statement	87917-CONSORT 2010 statement.pdf
Manuscript File	87917_Auto_Edited-CL-WangTQ-JLW.docx
Answering Reviewers	87917-Answering reviewers.pdf
Audio Core Tip	87917-Audio core tip.mp3
Biostatistics Review Certificate	87917-Biostatistics statement.pdf
Clinical Trial Registration Statement	87917-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	87917-Conflict-of-interest statement.pdf
Copyright License Agreement	87917-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	87917-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	87917-Language certificate.pdf
Peer-review Report	87917-Peer-review(s).pdf
Scientific Misconduct Check	87917-Bing-Lin C-2.png
Scientific Editor Work List	87917-Scientific editor work list.pdf
CrossCheck Report	87917-CrossCheck.png
CrossCheck Report	87917-CrossCheck report.pdf